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Autophagy
A cyto-protective mechanism which prevents
primary human hepatocyte apoptosis during oxidative stress
Ricky H. Bhogal,* Christopher J. Weston, Stuart M. Curbishley, David H. Adams and Simon C. Afford
Centre for Liver Research; The Institute for Biomedical Research; The Medical School; University of Birmingham; Birmingham, West Midlands UK
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The role of autophagy in the response of human hepatocytes to oxidative stress remains unknown. Understanding this
process may have important implications for the understanding of basic liver epithelial cell biology and the responses of
hepatocytes during liver disease. To address this we isolated primary hepatocytes from human liver tissue and exposed
them ex vivo to hypoxia and hypoxia-reoxygenation (H-R). We showed that oxidative stress increased hepatocyte
autophagy in a reactive oxygen species (ROS) and class III PtdIns3K-dependent manner. Specifically, mitochondrial ROS
and NADPH oxidase were found to be key regulators of autophagy. Autophagy involved the upregulation of BECN1,
LC3A, Atg7, Atg5 and Atg 12 during hypoxia and H-R. Autophagy was seen to occur within the mitochondria of the
hepatocyte and inhibition of autophagy resulted in the lowering a mitochondrial membrane potential and onset of cell
death. Autophagic responses were primarily observed in the large peri-venular (PV) hepatocyte subpopulation. Inhibition
of autophagy, using 3-methyladenine, increased apoptosis during H-R. Specifically, PV human hepatocytes were more
susceptible to apoptosis after inhibition of autophagy. These findings show for the first time that during oxidative stress
autophagy serves as a cell survival mechanism for primary human hepatocytes.
Introduction
Tissue hypoxia is a feature common to many liver diseases
including cirrhosis and cancer. It also occurs as a consequence
of hemodynamic shock and liver surgery. At the subcellular
level hepatocyte hypoxia causes depletion of glycolytic substrates,
loss of adenosine triphosphate and intracellular acidosis.
Moreover, following liver surgery/transplantation, the restoration
of blood flow, although restoring normal oxygen saturation
and acid-base balance paradoxically induces and augments
hepatocellular injury.1 The key mediator of these events is
accumulation of intracellular reactive oxygen species (ROS).2
Furthermore, ROS can regulate both human hepatocyte
apoptosis and necrosis during hypoxia and hypoxia-reoxygenation
(H-R).2
While hepatocyte apoptosis and necrosis have been shown to
occur during hypoxia, the role of hepatocyte autophagy remains
controversial. It is now widely recognized that autophagy is
required for protein and organelle turnover and is typically a
homeostatic cellular response to starvation. Furthermore, auto-
phagy degrades both long-lived cytoplasmic proteins and surplus
or dysfunctional organelles by lysosome-dependent mechanisms.3
Nearly all hepatocyte-derived proteins are long-lived and auto-
phagy is thought to be the primary process for hepatic protein
catabolism.4 Recent studies suggest that autophagy is another
distinct and separate form of cell death that hepatocytes sustain
when exposed to oxidative stress but it has been conclusively
shown that cells undergoing autophagy are not committed
irreversibly to death.5 The role of autophagy in liver disease has
been comprehensively presented in recent reviews.6,7
Autophagy is an active process which involves sequestration of
parts of the cytoplasm in double-membrane vesicles which then
fuse with lysosomes forming the autophagosome. The cytoplasmic
material engulfed is then hydrolysed permitting recycling of
amino acids and other macromolecular precursors.
In contrast to classical apoptosis, the cellular machinery that
regulates autophagy is known to be lysosomal proteinase-dependent
and caspase-independent. In particular the Atg proteins and
phosphatidylinositol 3-kinase (PtdIns3K) are crucial for autophago-
some assembly. The initial step of autophagosome formation
requires class III PtdIns3K and BECN1/Atg6 protein.8 The
assembly of the autophagosome can be inhibited pharmacologi-
cally by 3-methyladenine (3-MA), a specific class III PtdIns3K
inhibitor.9,10 The formation and expansion of the autophagosome
requires two protein conjugation systems that involve several of
members of the Atg protein superfamily,11 namely the Atg8/LC3-
PE and Atg12–Atg5 conjugation systems. These conjugation events
are regulated and involve Atg3, Atg4, Atg10.12 In particular Atg8
serves as a substrate for the Atg4 family of cysteine proteases.11 Many
Atg proteins can be regulated by ROS.11 Once activated Atg8 is
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able to associate with autophagosomes and remain there until fusion
with lysosomes.3,6
Under starvation, cellular generation of ROS is essential for
autophagosome formation and autophagic degradation. Because
we have observed that hepatocyte ROS generation is enhanced
during hypoxia, we wished in the present study, to define and
assess the role of hepatocyte autophagy during hypoxia and H-R.
We demonstrate for the first time that autophagy is essential for
protection of human hepatocytes against oxidative stress and
ROS-mediated cell death.
Results
Intracellular ROS accumulation is associated with increased
autophagy within human hepatocytes. Consistent with our
previous studies we show that exposure of human hepatocytes to
hypoxia and H-R increased human hepatocyte accumulation of
intracellular ROS as detected by DCF (Fig. 1A). These findings
were confirmed by the use of the mitochondrial ROS dye Mitosox
where we found that hypoxia and H-R also resulted in an increase
in mitochondrial ROS production (Fig. 1B). Indeed, mitochon-
drial ROS production accounts for the vast majority of ROS
production in human hepatocytes during hypoxia and H-R. This
increase in intracellular ROS accumulation during hypoxia and
H-R was also associated with an increase in the number of cells
undergoing autophagy as demonstrated by increased staining of
human hepatocytes with MDC (Fig. 2). The autophagic response
was greater during H-R than hypoxia. Furthermore, human
hepatocytes isolated from normal liver tissue and diseased liver
tissue show markedly different autophagic responses during
Figure 1. Intracellular ROS accumulation in primary human hepatocytes is mitochondrial dependent during hypoxia and H-R. (A) demonstrates
representative flow cytometry plots to illustrate the effects of normoxia (blue), hypoxia (hatched red) and H-R (solid gray) upon human hepatocyte ROS
production as assessed by DCF staining. A typical FS vs. SS plots of primary human hepatocytes during H-R is shown to the left of the flow cytometric
plot. Human hepatocytes are known to vary considerably in size and hence a large gate is required to include all cells in the analysis. Refer to
the Methods and Materials section for further details of the gating procedure and protocol. Similar FS vs. SS plots were obtained during normoxia and
hypoxia (data not shown). The areas of interest on the flow cytometric plots are marked by vertical ellipses. The area on the left of each ellipse represents
cell debris. Cell debris is included within the plot as human hepatocytes vary considerably in size and therefore to include all viable human hepatocytes
in the analysis a large gate is required on the flow cytometer, this by necessity includes the cell debris. The representative plot is of normal human
hepatocytes that have been isolated from benign liver diseases (n = 7). (B) shows composite bar charts to illustrate the effects of hypoxia and H-R upon
ROS production in human hepatocytes isolated from benign liver diseases using DCF and Mitosox. DCF is measure of hydrogen peroxide production
in human hepatocytes. Hydrogen peroxide is the main ROS generated within hepatocytes. Mitosox detects ROS generated specifically by
the mitochondrion. In these experiments human hepatocytes were isolated from the same liver wedges and then used simultaneously in our in vitro
model of hypoxia and H-R to determine DCF and Mitosox staining during normoxia, hypoxia and H-R. Data are expressed as mean fluorescence intensity
(MFI) and the values are derived from the gates shown in (A). Human hepatocytes used for these experiments were isolated from benign liver diseases
(n = 3–4). (*p , 0.05 relative to normoxia, **p , 0.05 relative to hypoxia, ***p , 0.01 relative to normoxia, Mann-Whitney test).
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hypoxia and H-R (Fig. 3). While human hepatocytes isolated
from biliary cirrhosis show a similar autophagic response to those
isolated from normal human hepatocytes (Fig. 2) those hepato-
cytes isolated from alcoholic liver disease (ALD) show very little
staining with MDC during hypoxia and H-R indicating the lack
of autophagy within these particular hepatocytes. Finally, human
hepatocytes from normal resected liver tissue that have been
exposed to chemotherapy showed a very different autophagic
response to hypoxia and H-R. These hepatocytes had a much
higher basal autophagy level that was maintained throughout
hypoxia and H-R. For the remainder of the experiments presented
in this study we used human hepatocytes isolated from normal
benign liver tissue.
Mitochondrial and NADPH oxidase mediate autophagy in
human hepatocytes during H-R. It has been previously shown
that ROS are critical regulators of autophagy.11 Accordingly,
during H-R, inhibition of ROS production inhibits autophagy in
primary human hepatocytes (Fig. 4). Specifically, inhibition of
mitochondrial complex I with rotenone and cytoplasmic NADPH
oxidase with diphenyliodonium significantly reduced MDC
staining of human hepatocytes, as assessed by flow cytometry.
Moreover, the general antioxidant N-acetylcysteine, which has the
greatest effect upon human hepatocyte ROS production,2 almost
completely inhibited autophagy in human hepatocytes. These
observations clearly demonstrate the central role of ROS in
regulating autophagy in human hepatocytes.
Inhibition of autophagy was associated with a concomitant
increase in hepatocyte apoptosis during H-R. We utilized the
specific class III PtdIns3K inhibitor 3-MA to elucidate the role of
autophagy in human hepatocytes. 3-MA significantly reduced
hepatocyte autophagy during H-R while the number of cells
undergoing apoptosis increased (Fig. 5). Similar data was obtained
during normoxia and hypoxia (data not shown). No significant
change in the number of cells undergoing necrosis was observed
during H-R with 3-MA pretreatment (Fig. 6). Similar data was
obtained during hypoxia (data not shown). Interestingly inhibi-
tion of class III PtdIns3K also decreased ROS accumulation
within human hepatocytes during H-R (Fig. 6).
Given that autophagy is regulated by a number of Atg proteins
we investigated whether these Atg proteins were modulated by
hypoxia and/or H-R. As Figure 7 demonstrates BECN1, an early
regulator of autophagy, is induced by hypoxia and H-R.
Interestingly, 3-MA reduces BECN1 protein levels during
normoxia, hypoxia and H-R. Similarly we found that Atg 5,
Figure 2. Intracellular ROS accumulation is associated with increased autophagy during hypoxia and H-R in human hepatocytes. This figure demonstrates
a representative flow cytometry plot to illustrate the effect of normoxia (blue), hypoxia (hatched red) and H-R (solid gray) upon autophagy within human
hepatocytes isolated from benign liver disease. Again, the areas of interest within the flow cytometry plots are marked by vertical ellipses. The same gate
has been applied to primary human hepatocytes for these plots as those shown in Figure 1A. The bar chart shows pooled data of five separate
experiments illustrating the effects of hypoxia and H-R upon human hepatocyte autophagy (n = 5). Data are expressed as increase relative to basal,
where basal refers to the level of autophagy during normoxia alone. Data are expressed as mean ± SE (*p , 0.05 relative to basal, Mann-Whitney test).
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Atg 7, Atg12 and LC3A were also increased during hypoxia, and
H-R and 3-MA pre-treatment of hepatocytes reduced the protein
levels of these Atg proteins. Additionally, cells treated with 3-MA
during normoxia, hypoxia and H-R showed the characteristic
morphological appearance of the cells undergoing apoptosis.
Hepatocytes appeared phase bright, small and shrunken (Fig. 8).
These observations clearly demonstrate that autophagy promotes
survival of human hepatocytes during hypoxia and H-R in vitro.
Much recent work has focused upon the role of mitochondrial
autophagy or mitophagy during oxidative stress.13-15 Indeed the
mitochondrion is an important ROS generator during IRI and is
known to regulate human hepatocyte apoptosis and necrosis.2
Figure 3. Differential levels of autophagy induction in human hepatocytes isolated from different liver diseases. This figure illustrates the level
of autophagy in human hepatocytes isolated from different liver diseases. The FS and SS plots for these hepatocytes are the same as those shown
in Figure 1A (n = 3–6).
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Accordingly, we used the specific mitochondrial dye JC-1 as a
measure of the mitochondrial membrane potential within
hepatocytes during hypoxia and H-R. Red fluorescence represents
normal mitochondrial membrane potential whereas green fluore-
scence represents low mitochondrial potential. In addition, human
hepatocytes were co-stained with MDC. As Figure 9 shows, during
normoxia human hepatocytes have normal mitochondrial
membrane potential with no staining for MDC. Interestingly,
incubation of cells with 3-MA markedly increased the green
fluorescence of human hepatocytes indicating a lowering of
mitochondrial potential and is indicative of cell death.
Furthermore, hypoxia and H-R lower mitochondrial membrane
potential further with a concomitant increase in MDC staining.
Moreover, pre-treatment of cells with 3-MA during hypoxia and
H-R, while reducing MDC staining markedly lowered mitochon-
drial membrane potential and increased cell death. Finally, MDC
and green JC-1 staining were observed to colocalize in these samples
indicating that autophagy was occurring in the mitochondrion.
Large peri-venular human hepatocytes preferentially undergo
autophagy during H-R. Our group has recently reported that
human hepatocytes located within the peri-venular (PV) region of
the liver, which tend to be larger in size than their peri-portal (PP)
counterparts, are the targets of hypoxic injury.16 Here we
demonstrate that large/PV hepatocytes (Fig. 10) increase auto-
phagy significantly more than PP/small human hepatocytes
during H-R (Fig. 11). As expected, these increased levels of
autophagy are sensitive to 3-MA pre-treatment. However,
inhibition of autophagy in large/PV human hepatocyte signifi-
cantly increased apoptosis during H-R (Fig. 4A).
Discussion
While autophagy is an important mechanism by which the cell
rids itself of potentially harmful constituents and helps maintain
normal cellular functioning and homeostasis, its precise role
during liver injury and disease where hepatocytes are involved
remains uncertain. A consensus is now emerging that autophagy
does not precede cell death but may be a physiologically protective
mechanism which favors cell survival.17 The diverse role of
autophagy in liver diseases has been recently reviewed.6,18,19
Certainly in liver IRI autophagy mainly has a prosurvival activity
allowing the cell to cope with hypoxia. However autophagy is also
Figure 4. Mitochondrial and NADPH oxidase mediate autophagy in human hepatocytes during H-R. This figure demonstrates representative flow
cytometry plots to illustrate the effects of NAC, rotenone and DPI upon human hepatocyte autophagy during H-R. The staining of cells with MDC during
H-R is shown in blue and the effects of NAC, rotenone and DPI are shown in solid gray. Similar data were obtained during normoxia and hypoxia
(data not shown). Again, the area of interest within the flow cytometry plots is marked by a vertical ellipse. The same gate has been applied to primary
human hepatocytes for these plots as those shown in Figure 1A. The bar chart shows pooled data of three separate experiments illustrating the effects
of NAC, rotenone, DPI upon human hepatocyte autophagy during H-R. Similar data were obtained during normoxia and hypoxia (data not shown).
Data are expressed as percentage inhibition relative to H-R, where the level of autophagy during H-R alone represents 100%. Data are expressed as
mean ± SE (*p , 0.05 relative to H-R alone, **p , 0.01 relative to H-R alone, Mann-Whitney test). Human hepatocytes used for these experiments were
isolated from benign liver diseases (n = 3–5).
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known to regulate hepatic steatosis and hepatitis virus replica-
tion.18 To our knowledge this is the first study to conclusively
demonstrate autophagy in isolated primary human cells under
conditions of hypoxic stress. This has potential implications for
our understanding of the hepatocyte response to liver injury and
development of chronic liver disease.
Previous tissue-based studies have shown autophagic hepato-
cytes within allografts are increased following liver transplantation.
However these studies failed to show a causal link between
oxidative stress, induction of cell death and autophagy.5 Instead it
was suggested that dying hepatocytes also increased autophagy.
However whether inhibition of autophagy promoted cell death or
survival was not demonstrated. Recent studies have shown that
the severity and duration of an ischemic insult determine whether
autophagy is induced or not. Indeed these studies have shown that
autophagy can delay the decision for a cell to die via apoptosis or
necrosis.20 We clearly show, using our novel four-color reporter
assay, that hepatocytes subjected to oxidative stress demonstrated
features consistent with increased ROS generation, autophagy and
apoptosis. However, crucially we show that inhibition of early
autophagy with the class PtdIns3K inhibitor, 3-MA, induces
increased levels apoptosis during H-R. For our presented study
we used 3-MA only and not siRNA knockdown or transfection
of human hepatocytes as these are notoriously difficult and
inefficient techniques.21-23 Importantly, inhibiting autophagy
causes the lowering of mitochondrial membrane potential and
leads to cell death. Previous authors have also reported that
autophagy is responsible for maintaining mitochondrial poten-
tial.19 Importantly, in the present study we have shown that
human hepatocytes isolated from normal and diseased liver tissues
have different autophagy responses during hypoxia and H-R.
Specifically, human hepatocytes isolated from normal resected
tissue, where livers would have been treated with chemotherapy,
showed MDC staining that was consistent throughout hypoxia
and H-R. Coupled with the findings of our previous study2 it can
be seen that these hepatocytes are also resistant to cell death
during hypoxia and H-R. Indeed, the reduction in cell death
maybe in part due to the induction of autophagy. This is
consistent with previous work performed in human livers.24
Moreover human hepatocytes isolated from ALD livers showed
no autophagy response during hypoxia and H-R possibly
reflecting the extent of damage to these livers. Human hepatocytes
isolated from biliary cirrhosis and normal benign liver showed
similar autophagy responses in an analogous manner to the
accumulation of ROS within these cells.2 These observations
show that the varying levels of intracellular ROS within human
hepatocytes isolated from different liver diseases correlates
positively with intracellular MDC staining and hence autophagy.
Figure 5. Inhibition of autophagy increases apoptosis in human hepatocytes during H-R. This figure illustrates representative flow cytometry plots to
demonstrate the effects of the pre-treatment of primary human hepatocytes with 3-MA and the resultant effects upon apoptosis and autophagy during
H-R. The level of apoptosis and autophagy during H-R are shown in blue and the effects of 3-MA pre-treatment are shown in solid gray. The area of
interest is marked with a vertical ellipse. The same gate has been applied to primary human hepatocytes for these plots as those shown in Figure 1A.
The bar charts to the right of each flow cytometry plot show pooled data from three separate experiments. Data are expressed as increase or decrease
relative to basal, where basal refers to the level of ROS production, apoptosis, necrosis or autophagy during H-R. Data are expressed as mean ± SE
(*p , 0.05 relative to basal, Mann-Whitney test). Human hepatocytes used for these experiments were isolated from benign liver diseases (n = 3).
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This finding also suggests that autophagy is differential induced in
different liver diseases and may have important implications for
disease pathogenesis.
During hypoxic stress, autophagy appears to occur within the
mitochondrion and our data shows that this process is likely to be
mediated by BECN1, LC3A, Atg 5, Atg 7 and Atg 12. Our
findings corroborate those in HeLa cells where inhibition of
autophagy also led to an increase in apoptosis.25 We illustrate, for
the first time, that the induction of autophagy within human
hepatocytes during oxidative stress is essential for cell survival.
Previous work by Kohli et al. in hepatocytes has shown that ROS
production lies upstream of PtdIns3K activation.26 Indeed,
inhibition of PtdIns3K with 3-MA did not lead to an increase
in BECN1, LC3A, Atg 5, Atg7 and Atg 12 protein levels which
were otherwise seen during hypoxia and H-R. Coupled together
these findings suggest that ROS activates PtdIns3K which sub-
sequently activates the remaining autophagy machinery (Fig. 12).
As stated above in hepatocytes autophagy targets mitochondria for
degradation, a process known as mitophagy. The finding that the
mitochondrion is the main ROS generator within human
hepatocytes would also fit with this observation particularly in
light of our previous findings that ROS can regulate autophagy,
apoptosis and necrosis. Inhibiting ROS inhibits all three cellular
processes, but selective inhibiting autophagy promotes apoptosis.
Furthermore, we demonstrate that the PV/large human hepato-
cytes increased levels of autophagy much more than PP/small
human hepatocytes in line with their greater susceptibility to
hypoxic injury. Moreover, inhibition of autophagy in PV/large
human hepatocytes increased apoptosis during H-R, clearly
demonstrating the link between autophagy and cell survival.
Central regulators of autophagy are the evolutionarily con-
served Atg genes and recent studies have shown that some Atg
proteins can be regulated by ROS.11 BECN1, an essential
regulator of early autophagy was induced by hypoxia and H-R and
efficiently inhibited by 3-MA. Recent reviews have detailed the
essential role of BECN1 in IRI27 as well as its central role in
mediating autophagy during oxidative stress.28 Moreover, under
stress hepatocytes utilize the LC3 protein to induce mitophagy
within the dysfunctional mitochondrion.29 This latter observation
is probably the role of increased LC3 seen in our in vitro model.
In an experimental rat model, short-term anoxia increases the
expression of Atg7 in hepatocytes and protects against anoxia-
reoxygenation mediated apoptosis and necrosis.1 We also found
an induction of Atg 7 during our model of IRI. Furthermore, we
found induction of Atg5 and Atg 12. These two Atg proteins are
involved in the latter processes of autophagy. Recent studies have
shown the integral role Atg 5 in regulating menadione-induced
oxidative stress.30 In this study knockdown of Atg 5 in the rat
hepatocyte line RALA255-10G sensitized cells to both apoptotic
and necrotic cell death. In addition Atg 12, along with other Atg
proteins, is required for the protection of anoxic rat hepatocytes
from cell death.31
Figure 6. Inhibition of autophagy reduces ROS production in human hepatocytes during H-R but does not affect necrosis. This figure illustrates
representative flow cytometry plots to demonstrate the effects of the pre-treatment of primary human hepatocytes with 3-MA and the resultant effects
upon intracellular ROS production and necrosis during H-R. The level of intracellular ROS production and necrosis during H-R are shown in blue and
the effects of 3-MA pre-treatment are shown in solid gray. The area of interest is marked with a vertical ellipse. The same gate has been applied to
primary human hepatocytes for these plots as those shown in Figure 1A. The bar charts to the right of each flow cytometry plot show pooled data from
three separate experiments. Data are expressed as increase or decrease relative to basal, where basal refers to the level of ROS production, apoptosis,
necrosis or autophagy during H-R. Data are expressed as mean ± SE (*p , 0.05 relative to basal, Mann-Whitney test). Human hepatocytes used for these
experiments were isolated from benign liver diseases (n = 3).
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Figure 7. BECN1, LC3A, Atg 5, Atg 7 and Atg 12 are induced by hypoxia and H-R in human hepatocytes. This figure illustrates the induction of various Atg
proteins involved in the regulation of autophagy during hypoxia and H-R. The effects of the PtdIns3K inhibitor 3-MA on Atg protein induction during
hypoxia and H-R are also shown. All western blots were performed at least three times and presented blots are representative of all samples (n = 3).
Figure 8. Inhibition of autophagy increases apoptosis in human hepatocytes during H-R. This figure shows representative light microscopy images of
primary human hepatocytes during normoxia, hypoxia and H-R in the presence and absence of 3-MA. In normoxia human hepatocytes are typical cuboid
morphology with many cells having the characteristic binucleate appearance. During hypoxia and H-R, cells lose this appearance and many cells appear
small shrunken in the confluent monolayer of cells, indicative of apoptotic bodies. Following 3-MA pretreatment in either normoxia, hypoxia or H-R many
more cells appear phase bright, small and shrunken. In addition there is disruption to the monolayer of hepatocytes. These light microscopy images have
been taken after 24 h incubation in hypoxia and H-R with and without the presence of 3-MA. (Magnification x20).
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While our study does not conclusively show which signaling
pathways are activated by ROS in human hepatocytes to induce
autophagy, it does clearly demonstrate that ROS is a key mediator
of autophagy during oxidative stress. Furthermore in accordance
with our study, previous authors have shown that the general anti-
oxidants, catalase and N-acetylcysteine reduce autophagy.11 We
now show that mitochondrial and NADPH oxidase derived ROS
are critical for the induction of autophagy in human hepatocytes.
In addition previous studies have shown that H-R induces
increased manganese superoxide dismutase expression in hepato-
cytes.32 Taken together these studies show that ROS derived from
many sources within hepatocytes can regulate autophagy.
Moreover this generated ROS has prosurvival effects in activating
autophagy but also signals to cell death in the form of apoptosis
and necrosis (Fig. 12). The increase in antioxidant defenses within
hepatocytes is likely to protect from cell death and the inhibition
of autophagy may not be detrimental as autophagy can be
regulated by other system besides ROS.33 These observations
provide interesting insights to the function of ROS in
determining human hepatocyte fate.2 Taken together, these
observations clearly point to ROS regulating diverse and different
signaling pathways within human hepatocytes during oxidative
stress. These pathways appear to regulate both cell death and cell
survival. It is likely that either the absolute level of intracellular
ROS, the type of ROS sub-species generated or duration of ROS
generation may be the critical factors in determining cell fate. The
precise mechanistic pathways remain to be elucidated but may
ultimately provide insights which inform the development of
therapeutic strategies aimed at limiting the cellular damage and
loss associated with liver injury. Previous authors have reported
that inhibiting autophagy within rat hepatocytes leads to
necrosis.34 Moreover, in a model of ischemic preconditioning
Esposti et al. reported that autophagy may switch necrosis and/or
apoptosis on and off by modulating intracellular signaling.35 We
did not find this and it is likely that this represents species-specific
effects of autophagy as no previous studies have evaluated
Figure 9. Autophagy is primarily performed inmitochondrion in human hepatocytes during hypoxia and H-R. This figure demonstrates the effects of hypoxia
and H-R upon human hepatocyte mitochondrial membrane potential and MDC staining. Mitochondrial membrane potential was determined using
the specific dye JC-1. When mitochondrial membrane potential is normal JC-1 appears red but once membrane potential is lowered or lost the dye become
green. MDC staining is detected within the DAPI channel and appears blue. Composite overlay images are shown at the bottom of the figure. Additionally
unstained images are provided with stained images to highlight the cellular location of immunofluorescence. In normoxia, as expected there was a normal
mitochondrial membrane potential and no autophagy noted. During hypoxia and H-R there was a progressive loss of red JC-1 staining and an increase in
green JC-1 staining indicating loss of mitochondrial potential and onset of cell death. In addition there was an increase inMDC staining in human hepatocytes
during hypoxia and H-R. Moreover, MDC staining and green JC-1 staining co-localized in human hepatocytes during hypoxia and H-R.
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autophagy in human hepatocytes. It may also represent a
difference between the induction of autophagy in the in vitro
and in vivo setting.
Our study demonstrates that ROS production decreased within
human hepatocytes after 3-MA pre-treatment during H-R. One
would expect that in hepatocytes in which autophagy was
inhibited damaged mitochondria would continue to form ROS
and induce cell death. However, the particular model utilized in
our experiments examines cell death and ROS production at 24 h
of hypoxia and/or H-R. The significant levels of apoptosis seen
after 3-MA pretreatment during H-R suggests that a significant
number of hepatocytes were already dead, hence intracellular
ROS had reduced. Importantly, our study showed no significant
effect of vehicle controls on human hepatocyte ROS production
during H-R.
We provide evidence that within human hepatocytes, auto-
phagy is a cell-survival mechanism during periods of oxidative
stress. Moreover, taken together with previous studies, we show
that the PV/large human hepatocytes increase autophagy signifi-
cantly more in H-R relative to PP/small human hepatocytes. This
is in accordance with our previous observations that the PV/large
peri-venular human hepatocytes are more susceptible to oxidative
stress. These observations suggest that the pharmacological
activation of P13-K or other autophagy machinery, particularly
within PV/large human hepatocytes may prove effective strategies
in ameliorating human hepatocyte cell death in chronic liver
disease as well as following liver transplantation.
Materials and Methods
Human hepatocyte isolation. Liver tissue was obtained via the
Hepatobiliary and Transplant surgery program at the Queen
Elizabeth Hospital Birmingham UK, from fully consenting
patients undergoing transplantation, hepatic resection for liver
metastasis, hepatic resection for benign liver disease or normal
donor tissue surplus to surgical requirements. Ethical approval for
Figure 10. Autophagic response in large human hepatocytes during hypoxia and H-R. The top panel demonstrates a representative flow cytometry plot
to illustrate the levels of MDC staining of PV/large human hepatocytes during normoxia (blue), hypoxia (hatched red) and H-R (solid gray). The plot
on the left hand side of the flow cytometric plot represents a typical FS vs. SS plot, similar to that shown in Figure 1A . The FS vs. SS plot is from a H-R
sample but similar plots were obtained during normoxia and hypoxia (data not shown). The gating protocol applied to human hepatocytes to analyze
PV/large human hepatocytes is shown on the FS vs. SS plot. The area of interest of each flow cytometry plot is marked by a vertical ellipse. The bottom
panel illustrates the effects of 3-MA pre-treatment upon PV/large human hepatocyte autophagy and apoptosis during H-R. The effects of H-R alone are
shown in blue and the effects of 3-MA pretreatment are shown in solid gray. The bar chart shows composite data from four separate experiments.
Data are expressed as mean ± SE (*p , 0.05 relative to basal, Mann-Whitney test).
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the study was grant by the Local Research Ethics Committee
(LREC) (reference number 06/Q702/61). Human hepatocytes
were isolated using the method that we have described
previously.36 Normal benign livers were classified as livers where
resection was performed for recurrent cholangitis, haemangioma
and focal nodular hyperplasia. Biliary cirrhosis livers included
livers with both primary biliary cirrhosis and primary sclerosing
cholangitis. Normal resected liver tissue was tissue taken from
surgical resections performed for metastatic disease. Tissue was
taken well away from the tumor site and all such patients had
received pre-operative chemotherapy.
Model of hypoxia and H-R. In experiments, human hepato-
cytes were grown for 2 d at 37°C, 5% CO2 in Williams E media
(Sigma-Aldrich, W4125) on rat type 1 collagen-coated plates.
Hepatocytes were either maintained in normoxia or placed into
hypoxia for 24 h, or placed into hypoxia for 24 h followed by 24 h
of reoxygenation. Hypoxia was achieved by placing cells in
an airtight incubator (RS Mini Galaxy A incubator, Wolf
Laboratories) flushed with 5% CO2 and 95% N2 until oxygen
content in the chamber reached 0.1%, as verified by a dissolved
oxygen monitor (DOH-247-KIT, Omega Engineering, UK). In
preliminary experiments, human hepatocytes were exposed to 5%
and 1% oxygen and no increase in ROS accumulation or cell
death was noted. Therefore, we used 0.1% oxygen in all
subsequent experiments. Additionally, Williams E media was
pre-incubated in the hypoxic chamber in a sterile container, which
allowed gas equilibration, for 8 h before experiments were
performed, resulting in a final oxygen concentration of, 0.1% as
measured with the dissolved oxygen meter. Where appropriate,
after 24 h of hypoxia media was aspirated and replaced with fresh,
warmed, oxygenated medium, and the cells were returned to
normoxic conditions. This was defined as the beginning of
reoxygenation. In experiments involving ROS inhibitors/antioxi-
dants all reagents were made fresh as stock solutions and added
using the correct dilution factor to the relevant experimental wells.
Specifically, N-acteylcysteine (Sigma-Aldrich, A9165) was dis-
solved in molecular grade water (Sigma-Aldrich, W4502) to a
concentration of 100 mM, rotenone (Sigma-Aldrich, R8875) was
dissolved in chloroform (Sigma-Aldrich, C2432) to a concentra-
tion of 1 mM and diphenyliodonium (Sigma-Aldrich, 43088) was
Figure 11. Autophagic response in small human hepatocytes during hypoxia and H-R. This figure demonstrates a representative flow cytometry plot to
illustrate the levels of MDC staining of PP/small human hepatocytes during normoxia (blue), hypoxia (hatched red) and H-R (solid gray). The FS vs. SS plot
is from a H-R sample but similar plots were obtained during normoxia and hypoxia (data not shown). The gating protocol applied to human hepatocytes
to analyze PP/small human hepatocytes is shown on the FS vs. SS plot. The areas of interest on the flow cytometric plots are marked by vertical ellipses.
The bottom panel illustrates the effects of 3-MA pre-treatment upon PP/small human hepatocyte autophagy and apoptosis during H-R. The effects of H-R
alone are shown in blue and the effects of 3-MA pretreatment are shown in solid gray. The bar chart shows composite data from four separate
experiments. Data are expressed as mean ± SE (*p , 0.05 relative to basal, Mann-Whitney test).
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dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, D2650)
to give a stock concentration of 1 mM, and these stocks were
diluted appropriately to give working concentrations of 20 mM,
2 mM and 10 mM respectively. In experiments using ROS
inhibitors/antioxidants, solvent alone controls were used to ensure
no vehicle effects. In addition, in experiments using ROS
inhibitors/antioxidants agents were added 4 h before the
placement of the cells into hypoxia or into reoxygenation.
In experiments involving the use of 3-MA (Merck,
Nottingham, 189490), stock solutions were made and added to
the correct final dilution factor in the relevant tissue culture wells.
3-MA is a specific class III PtdIns3K inhibitor and specifically
inhibits the early phases of autophagy. Specifically, 2 mg 3-MA
was dissolved in molecular grade DMSO (Sigma-Aldrich) and
were diluted appropriately to give working concentrations of
5 mM. In experiments using 3-MA, solvent alone wells were
included as vehicle only controls. Hepatocytes were pre-treated
with 3-MA for up to 4 h before placement of the cells into
normoxia and hypoxia. For H-R experiments fresh 3-MA was
added at the time of placement into reoxygenation.
Determination of human hepatocytes ROS accumulation,
apoptosis, necrosis and autophagy. ROS production, apoptosis,
necrosis and autophagy were determined by using
a four-color reporter assay system. ROS accu-
mulation was determined using the fluorescent
probe 2',7'-dichlorofluorescin-diacetate (Merck,
287810).37 This probe is cell permeable and once
inside the cell is cleaved by intracellular esterases
to 2',7'-dichlorofluorescin (DCF) and becomes
cell impermeable. DCF is then able to react with
intracellular ROS, specifically hydrogen peroxide,
to give a fluorescent signal detectable on the
FITC channel. The signal is directly proportional
to the level of intracellular ROS present.
MitoSox Red is a mitochondrial superoxide
indicator dye (Molecular Probes, Invitrogen,
M36008) and was used as an alternative means
to determine ROS in the mitochondria. Cells
were treated as described above in the in vitro
model and then loaded with 5 mM MitoSox Red
in Hank’s Balanced Salt Solution (HBSS) (Gibco,
14180046) for 30 min at 37°C in the dark. Cells
were washed as described below. MitoSox Red
fluorescent intensity was determined by fluore-
scence with excitation at 510 nm and emission at
580 nm.
Apoptosis was determined by labeling cells
with Annexin-V (Molecular Probes, Invitrogen,
A35122) which detects exposed phosphatidyl-
serine on the cell membrane. 7-Amino-
Actinomycin D (7-AAD) (Molecular Probes,
Invitrogen, A1310) is a vital dye that binds to
DNA, only entering cells once the cell membrane
is disrupted and is indicative of cellular necrosis.
Autophagy formation was determined by
using the fluorescent dye monodansylcadaverine
(MDC) (Sigma-Aldrich, 30432). This dye selectively labels
autophagic vacuoles38 and has been previously used in hepatoma
cell lines39 and primary hepatocytes40 to detect autophagy.
Following treatment, cell media was aspirated and replaced with
HBSS without calcium and magnesium. DCF (30 mM) and
MDC (1 mM) was added and the cells were incubated for 20 min
in the dark at 37°C. The cells were then trypsinized and washed
extensively in FACs buffer (phosphate-buffered saline pH 7.2
with 10% v/v heat inactivated fetal calf serum (Gibco) Sigma-
Aldrich, F6178). Cells were then labeled with Annexin-V
(0.25 mg/ml) and 7-AAD (1 mg/ml) for 15 min while on ice
and then samples were immediately subjected to flow cytometry.
At least 20,000 events were recorded within the gated region of
the flow cytometer for each human hepatocyte cell preparation in
each experimental condition. Only the cells within the gated
region were used to calculate Mean Fluorescence Intensity (MFI).
To ensure consistency of the flow cytometric data, each human
hepatocyte preparation was labeled with DCF alone, Annexin-V
alone, 7-AAD alone and MDC alone to ensure that cells had
become labeled and that the flow cytometry data could be
compensated for crossover of fluorophore emission spectra. The
same flow cytometry protocol was used for all experiments shown
Figure 12. The proposed regulation of autophagy in human hepatocytes during hypoxia
and H-R. Hypoxia and H-R leads to the generation of ROS in human hepatocytes
predominantly in a mitochondrial dependent manner. As our previous work has
demonstrated this increased ROS during hypoxia and H-R can lead to both apoptosis and
necrosis2 (black arrows). However, the increased ROS can also activate autophagy which
can be inhibited by the ROS inhibitors NAC, rotenone or DPI leading to reduced levels of
apoptosis, necrosis and autophagy. As Kohli et al. have demonstrated in hepatocytes, ROS
can activate PI3-K34, the essential first step in the assembly of the autophagosome.
Once activated a number of Atg proteins including BECN1, LC3A, Atg5, Atg7 and Atg12 are
involved in maturation of the autophagosome. It appears that the autophagy process
predominantly removes dysfunctional mitochondria in human hepatocytes during hypoxia
and H-R which in turns aids cell survival (green arrows). Inhibiting PtdIns3K with 3-MA
ensures that the autophagosome does not develop and that Atg proteins are not induced
in human hepatocytes during hypoxia and H-R (red arrows). Consequently, human
hepatocytes are not able to carry out autophagy and thus mitochondria lose their
membrane potential and are committed to cell death in the form of apoptosis.
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within the study, i.e. voltages for all markers were constant for
all human hepatocyte preparation ensuring inter- and intra-
experimental consistency. Specifically, for each experiment a cell-
only sample was used to ensure that there was no staining of
primary human hepatocytes with each specific dye/probe. This
sample was also used to ensure that the MFI reading was placed in
the first decade for each dye/probe. Also these cells were used to
place a flow cytometric gate for subsequent samples. Human
hepatocytes vary considerable in size depending upon whether
they are derived from the peri-venular region of the liver or peri-
portal region of the liver. Therefore forward scatter (FS) and side
scatter (SS) as shown in Figure 1A demonstrate a heterogeneous
cell population. A gate was therefore placed in FS vs. SS that
included all cells. Clearly, the sample includes cell debris that by
necessity is included within the large gate applied in the analysis.
Also, the gate will include small hepatocytes and hepatocytes that
attain lower intensity of staining with probes/dyes and do not
respond to hypoxia and H-R in the same way as the highly stained
species. Therefore, peaks seen adjacent to the vertical ellipses of
interest represent cell debris and hepatocytes that have different
responses to hypoxia and H-R.
Western blotting. For western immunoblotting studies, human
hepatocytes were lysed at the end of the relevant experimental period
using NP-40 lysis buffer (20 mM TRIS-HCl pH 8 (Sigma-Aldrich,
T3253), 137 mM NaCl (Sigma-Aldrich, S3014), 10% glycerol
(Sigma-Aldrich, G5516), 1%Nonidet P40 (Sigma-Aldrich, 18896),
2 mM EDTA (Sigma-Aldrich, E6758). Protein concentration was
determined by Bradford protein assay and 25 mg of protein was
resolved on a 10% SDS-PAGE gel and transferred to a nitrocellulose
membrane (Hybond; Amersham Biosciences, RPN3032D). The
blotted membrane was blocked for 1 h at room temperature in Tris-
buffered saline (TBS) pH 7.4/Tween 0.1% (Sigma-Aldrich, P9416)
containing 5% (wt/vol) bovine serum albumin (BSA) (Sigma-
Aldrich, A9418). All primary antibody incubations were performed
at overnight at 4°C in TBS-Tween 0.1% containing 5% BSA
(wt/vol). The incubation steps were followed by three washing steps
of 5 min with TBS containing 0.1% Tween. All primary antibodies
were purchased from New England Biolabs and used at a dilution
of 1:1000 as per manufacturer’s instructions. Specific primary
antibodies used included: (1) BECN1 (3495), (2) LC3A (4599), (3)
Atg5 (8540), (4) Atg12 (4180) and (5) Atg7 (2631).
Binding of specific mAb was detected with a horseradish
peroxidase-conjugated anti-rabbit IgG at a dilution of 1:2000 for
1 h (Sigma-Aldrich, A8792) Protein bands were visualized using
the enhanced chemiluminescence detection system (Amersham
Biosciences, RPN2109) followed by exposure of the membranes
to Hyperfilm-ECL (Amersham Biosciences, 28-9068-37).
Equality of protein loading on were checked by immunoblotting
for β-actin (Sigma-Aldrich, A2228) (dilution 1:20000). All
Western immunoblots were performed at least three times from
different liver preparations for each liver cell type.
Assessment of mitochondrial membrane potential and
labeling of autophagic vacuoles with MDC. To measure the
mitochondrial membrane potential (DYm), 5,5',6,6'-tetrachloro-
1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1)
(Molecular Probes, Invitrogen, M34152), a sensitive fluorescent
probe for DYm was used.41 Human hepatocytes were used in in
vitro experiments as described above. At the end of the specific
experimental procedure, cells were then rinsed with PBS twice
and then stained with 5 mM JC-1 and/or 1 mM MDC for 30 min
at 37°C. Cells were rinsed with ice-cold PBS twice, resuspended
in 1 mL ice-cooled PBS, and immediately analyzed with a
fluorescence microscope (Nikon Eclipse TE 300). A 488 nm filter
was used for the excitation of JC-1. Emission filters of 535 nm
and 595 nm were used to quantify the population of mito-
chondria with green (JC-1 monomers) and red (JC-1 aggregates)
fluorescence, respectively.42
MDC staining was assessed with a filter system (V-2A
excitation filter: 380/420 nm, barrier filter: 450 nm).43 Images
were captured with a CCD camera and imported into Adobe
Photoshop.
Statistical analysis. All data are expressed as mean ± SE.
Statistical comparisons between groups were analyzed by Mann-
Whitney test. All differences were considered statistically signifi-
cant at a value of p , 0.05.
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